front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |review |
It would take an
enourmously astute clinician to tell—using casual clinical observations—the difference
between the first and second bars. So the clinical impression is that there is no
clinically important interaction. Note that the INX is likely to help some patients by getting them out of the subtherapeutic range (2nd bar). Hence, if the severity of the toxicity is modest, you might do as much good as harm from this interaction (albeit inadvertantly). |